Confidence Inside the Vial and Far Beyond

GE Healthcare has a long history of providing safe and reliable radiopharmaceutical products, and we continue to build on our leadership in the Neurology space aiming to offer our customers, in both clinical and research settings, a wider choice of diagnostic tracers across PET and SPECT to better serve the Neurology community.
Confidence Inside the Vial and Far Beyond
When you choose DaTscan, you choose a product that extends far beyond the vial. You gain a reliable and trusted partner in GE Healthcare dedicated to support your team for optimal DaTscan image quality and patient care.  
Like DaTscan, we are reliable when you need us.
DaTscan Benefits
Dedicated Clinical Sales Team  
Customer Service Support
Technical Support
Ordering Guidance
Applications Training
Clinical and Scientific Support
Reimbursement Support
Educational Programs
Learn more about DaTscan imaging
DaTscan (Ioflupane I 123 Injection) is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single-photon emission computed tomography (SPECT) brain imaging to assist in the evaluation of adult patients with suspected parkinsonian syndromes (PSs). In these patients, DaTscan may be used to help differentiate essential tremor from tremor due to PS (idiopathic Parkinson's disease [PD], multiple system atrophy [MSA], and progressive supranuclear palsy [PSP]). DaTscan is an adjunct to other diagnostic evaluations. DaTscan was not designed to distinguish among PD, MSA, and PSP. The effectiveness of DaTscan as a screening or confirmatory test and for monitoring disease progression or response to therapy has not been established.

Prior to DaTscan administration, please read the Full Prescribing Information for additional Important Safety Information.
Clinical Applications Specialists Provide:
DaTscan applications training customized to the needs of you and your team
Clinical support and training on GE Healthcare's reporting software
Support for optimizing imaging protocols and image quality
Medical Affairs Team:
Prompt responses to scientific and clinical queries
Collaborates with the healthcare community to address knowledge gaps and improve patient outcomes
Supports your clinical research needs
Market Access Team:
The Market Access team is available to provide guidance on coding, reimbursement, and prior authorizations in order to help get your claims paid. Our team:
Actively engages with commercial and government payers on coverage decisions and proposed payment policies
Provides information to payers on the clinical and economic value of our products
Can connect you with Reimbursement HUB services to facilitate easier prior authorizations and review of denied claims
Our vision is to deliver on the promise of precision health from injection to diagnosis.
Each dose, each patient, improving every day.
Confidence Inside the Vial and Far Beyond
DaTscan is contraindicated in patients with known hypersensitivity to the active substance, any of the excipients, or iodine
In clinical trials, headache, nausea, vertigo, dry mouth, or dizziness of mild to moderate severity were reported. In postmarketing experience, hypersensitivity reactions and injection-site pain have been reported
Prior to DaTscan administration, please read the Full Prescribing Information for additional Important Safety Information.
Learn more about DaTscan imaging
© 2022 General Electric Company GE, the GE Monogram, and DaTscan are trademarks of General Electric Company.
Any third-party trademarks are the property of their respective owners.

December 2021 JB06256US
•  Do not reply to this email as it was sent from an unmonitored account.
•  Unsubscribe from the Breaking News.
•  Reset your password.
•  Contact support.
• Privacy Policy.
•  Email sent to: ., 671 N Glebe Road, Suite #1610, Arlington, VA 22203 USA
+1 520-298-1000